Immunological Aspects Of The Renal System - Shnyra Flashcards
isschemic AKI leads to what
Metabolic Acidosis + ATP depletion
Acute renal Failure
Acute renal failure
abrupt decrease in kidney function
major cause of AKI
sterile inflammation (hypoxia)
when necrosis from ischemia of kidney tissue OR ECM causes DAMP release
= activate APCs, C-Reactive Proteins —-> CP, TLRs
C-reactive proteins activate what
classical pathway
wha do APCs release
TNF-a, IL-6, IL-1B
when complement pathway is activated on kidney cells what happens
C3a and C5a are also chemoattractants = inflammation + death of cell
reason kidney is so susceptible to complement activation
high filtration rate causes deposition of immune complexes
profibrotic factors
TGF-B = activate fibroblasts
most N and M come to kidney from
Complement activation
how are phagocytes activated
Fc-receptor
N release what
proteases, free radicals
what do monocytes release
—-> M1 that go into glomeruli,
NO, ROS, cytokines, GFs, chemokines
= vascular injury and cell proliferation
early AKI
Th1, Th17, M1
tissue injury
AKI tissue repair is done by what cells
M2
Late AKI
Th1
what is the function of Th17 cells steps
- APC + CD4 cell
- Th17 cells activated release IL17, IL22
- IL17 bring release CCL20 for inflammation
- IL22 controls homeostasis and increased barrier function
what happens what TH17 cells release IL17
CCL20 is expressed which activates:
N, M, Th1—-> M1, TH17
what does Th1 cells secrete
INF-g to recruit M1 cells + IgG that bind to Fc receptors
what activated Th1 cells
APC —-> IL12
what do Th2 cells release
IL13, IL4 —-> M2
what do M2 cells release
TGF-B, IL10 (pericyte accumulation, myofibroblast differentiation, ECM production)
how are M1 —-> M2
M reprogramming (CSF-1 (M-CSF), IL10
CD25 causes what cytokine
IL2
Treg cells and AKI
low Tregs leads to increased AKI risk
Treg has what receptor important for preventing AKI
ANTI-CD25
AKI can be what types of hypersensitivity
2, 3
Type 2 AKI
IgG, IgM, cell bound Ag
Complement activation + lysis
Type 3 AKI
IgG, IgM, soluble Ag
Ab-Ag deposited in tissues
Complement activation and Neutrophils
which HLA is most important in transplant testing
HLA 1 (since HLA 2 is only on APCs that are mostly killed in the donor organ)
H vs G Hyperacute
Type 2
Abs, complement : ABO blood type mismatch
immediate
H vs G Acute
Type 4
T-cells, Th1, Th17, CD8+
Days to weeks
H vs G Chronic
Type 3,4
due to vascular trauma, T-cells, CD4, M2, Abs (maybe Th1)
Months to years
has to do with quality and timing of transplant
autograft
isograft
allograft
xenograft
same person
identical twin
same species
different species (can cause rapid complement attack)
4 things for a good transplant
- quality of organ + allograft
- HLA matching
- host anti-donor response strength should be low
- apply immunosuppression
when a damaged graft is transplanted what happens in steps
- graft tissues release DAMPS
- Clotting cascade (fibrin) + increase permeability of leukocytes
- Kinin cascade : vasodilation + permeability
- hyperacute if not controlled
ABO matching is not important when and for what reason
- cornea, heart valve, bone, tendon
= non-vascularized + limited immune cell access - stem cells (they have no HLA1)
ABO incompatibility for kidney transplant can still be done how
by intensified immunosuppression
Microcytotoxicity Test
- recipient Abs are added to donor cells
- add complement
- add dye
- if dye is inside cells = Abs attacked donor cells
Microcytotoxicity Test for HLA 1
- get lymphocytes from spleen/ LN (donor) + peripheral blood (recipient)
- Anti-HLA (from volunteers) added
- add complement and add dye
- if both donor lymphocyte and recipient lymphocyte act the same to anti- HLA = MATCH
Microcytotoxicity Test for HLA 2
- T-cells from R and D (Dead after radiation) are added
- R T-cells need to find the D Ag-Tcell or Ag-DC and proliferate
- the more R t-cells proliferate = the more of a mismatch
adaptive allograft rejection is stronger then adaptive pathogen response becuz
more t-cells are activated
if reaction happened to first graft then second graft from same donor
will be even stronger and so extensive testing should be done before
Direct allorecognition
- R T-cells start to come to organ when BF increases
- R T-cells find DAMPS —-> D DC
- D DC go to LN —-> R T-cells (LN)
Indirect Allorecognitino
- R T-cells start to come to organ when BF increases
- R T-cells find DAMPS —-> R DC
- R DC go to LN to tell more R T-cells
Th2 allograft rejection
Th2 —-> IL4, IL5 —-> Abs (humoral)
Th1 allograft rejection
Th1 —-> IL2, IFN-g —-> CD8+ (cell mediated)
Acute H vs G rejection steps
- D T-cells –> D DCs (from DAMPS)
- D DCs —-> LN
- activate R T-cells
- CD8+ type 4 HS,
* direct + indirect pathway and TLRs
Chronic H vs G rejection happens due to
ischemia from occluded BVs (from chronic rejection)
- M2 release TGF-B = SM proliferation
- Abs —-> complement
* *** does not respond to immunosuppressents
* indirect pathway + Abs
other things that could cause chrinic rejection
- ischemic reperfusion before transplant
- own kidney failure
- nephrotoxicity (Cyclosporine A) = immunosuppressants for preventing acute rejection
G vs H
what is the cause
Type 4 (usually BM, Liver, GI that you cant kill all donor APCs and t-cells)
- Donor T-cells proliferate and attack R minor H-Ags on its T-cells
- D T-cells go to LN and make R -Tcells attack its own immune system (HLA 1 and HLA 2)
- usually in immunosuppressed people
- CD8+, CD4+
G vs H
Sx:
how to Tx:
jaundice
D, Rash
Tx : DONT use immunosuppressants
Acute G vs H
cell death
jaundice , Rash, D, GI hemorrhage
Chronic G vs H
Fibrosis + atrophy
Dysfunction of organ
2 ways G vs H kill target cells
- Fas-FasL (CD3, TCR)
- Perforin/Granzyme (DNA fragments)
* * BOTH USE CD8+ (CTL)**